Date
Title
View
19 Mar 18
SYGNIS AG: SYGNIS AG to raise capital via a private placement of new shares to acquire TGR Biosciences
View
15 Mar 18
SYGNIS AG: SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth (news with additional features)
View
13 Mar 18
SYGNIS AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
View
06 Mar 18
SYGNIS completes integration of acquired companies’ products and services under Expedeon brand name (news with additional features)
View
21 Feb 18
SYGNIS AG: SYGNIS AG extends OEM agreement with leading global research tools provider (news with additional features)
View
25 Jan 18
SYGNIS AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
View
25 Jan 18
SYGNIS AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
View
22 Jan 18
SYGNIS AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
View
22 Jan 18
SYGNIS AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
View
04 Jan 18
DGAP-DD: SYGNIS AG english
View
04 Jan 18
DGAP-DD: SYGNIS AG english
View
06 Dec 17
SYGNIS AG: SYGNIS AG launches TruePrime(TM) apoptotic cell free DNA amplification kit for the liquid biopsy market (news with additional features)
View